Cargando…
Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01
Vesicular stomatitis virus (VSV) has been extensively utilized as a viral vector system for the induction of protective immune responses against a variety of pathogens. We constructed recombinant VSVs specifying either the Indiana or Chandipura virus G glycoprotein and expressing the West Nile virus...
Autores principales: | Iyer, Arun V., Pahar, Bapi, Boudreaux, Marc J., Wakamatsu, Nobuko, Roy, Alma F., Chouljenko, Vladimir N., Baghian, Abolghasem, Apetrei, Cristian, Marx, Preston A., Kousoulas, Konstantin G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115407/ https://www.ncbi.nlm.nih.gov/pubmed/19070640 http://dx.doi.org/10.1016/j.vaccine.2008.11.087 |
Ejemplares similares
-
A Review of Vaccine Approaches for West Nile Virus
por: Iyer, Arun V., et al.
Publicado: (2013) -
Management of West Nile Encephalitis: An Uncommon Complication of West Nile Virus
por: Alli, Ammar, et al.
Publicado: (2021) -
West Nile Virus, Venezuela
por: Bosch, Irene, et al.
Publicado: (2007) -
West Nile Virus in California
por: Reisen, William, et al.
Publicado: (2004) -
West Nile Virus, Guadeloupe
por: Quirin, René, et al.
Publicado: (2004)